Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings, Appropriated [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2023	32,490,119
Balance at Dec. 31, 2023	$ 89	$ 614,035	$ (679,348)	$ 12	$ (65,212)
Exercise of options into ordinary shares (in shares)	378,800
Exercise of options into ordinary shares	$ 1	249			250
Share-based compensation		9,805			9,805
Issuance of ordinary shares, net of issuance costs (in shares)	9,321,896
Issuance of ordinary shares, net of issuance costs	$ 25	151,144			151,169
Other comprehensive income				224	224
Net loss			(89,362)		(89,362)
Other comprehensive loss				224	224
Issuance of pre-funded warrants, net of issuance costs		18,641			18,641
Balance (in shares) at Sep. 30, 2024	42,190,815
Balance at Sep. 30, 2024	$ 115	793,874	(768,710)	236	25,515
Balance (in shares) at Jun. 30, 2024	41,169,954
Balance at Jun. 30, 2024	$ 112	775,270	(745,037)	(31)	30,314
Exercise of options into ordinary shares (in shares)	99,433
Exercise of options into ordinary shares	$ 0	115			115
Share-based compensation		3,489			3,489
Issuance of ordinary shares, net of issuance costs (in shares)	921,428
Issuance of ordinary shares, net of issuance costs	$ 3	15,000			15,003
Other comprehensive income				267	267
Net loss			(23,673)		(23,673)
Other comprehensive loss				267	267
Balance (in shares) at Sep. 30, 2024	42,190,815
Balance at Sep. 30, 2024	$ 115	793,874	(768,710)	236	25,515
Balance (in shares) at Dec. 31, 2024	42,231,746
Balance at Dec. 31, 2024	$ 115	797,248	(806,222)	56	(8,803)
Exercise of options into ordinary shares (in shares)	552,103
Exercise of options into ordinary shares	$ 2	627			629
Share-based compensation		8,829			8,829
Issuance of ordinary shares, net of issuance costs (in shares)	791,091
Issuance of ordinary shares, net of issuance costs	$ 2	11,095			11,097
Other comprehensive income				(33)	(33)
Net loss			(127,130)		(127,130)
Conversion of pre-funded warrants into ordinary shares (in shares)	3,206,271
Conversion of pre-funded warrants into ordinary shares	$ 9	(6)			3
Other comprehensive loss				(33)	(33)
Balance (in shares) at Sep. 30, 2025	46,781,211
Balance at Sep. 30, 2025	$ 128	817,793	(933,352)	23	(115,408)
Balance (in shares) at Jun. 30, 2025	46,199,134
Balance at Jun. 30, 2025	$ 126	806,497	(900,005)	6	(93,376)
Exercise of options into ordinary shares (in shares)	165,829
Exercise of options into ordinary shares	$ 1	301			302
Share-based compensation		3,027			3,027
Issuance of ordinary shares, net of issuance costs (in shares)	416,248
Issuance of ordinary shares, net of issuance costs	$ 1	7,968			7,969
Other comprehensive income				17	17
Net loss			(33,347)		(33,347)
Other comprehensive loss				17	17
Balance (in shares) at Sep. 30, 2025	46,781,211
Balance at Sep. 30, 2025	$ 128	$ 817,793	$ (933,352)	$ 23	$ (115,408)